Y H Min

Summary

Affiliation: Yonsei University
Country: Korea

Publications

  1. ncbi request reprint Surface expression of HLA-DM on dendritic cells derived from CD34-positive bone marrow haematopoietic stem cells
    Y H Min
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Br J Haematol 110:385-93. 2000
  2. ncbi request reprint Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia
    Yoo Hong Min
    Department of Internal Medicine, Yonsei University College of Medicine, Seodaemun ku Shinchon dong 134, Seoul 120 752, Korea
    Cancer Res 64:5225-31. 2004
  3. ncbi request reprint Long-term bone marrow culture-derived stromal fibroblasts as a potential target for gene therapy in acute myelogenous leukemia
    Yoo Hong Min
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
    Leuk Res 26:369-76. 2002
  4. ncbi request reprint Transplantation of peripheral blood stem cells mobilized by intensified consolidation and granulocyte colony-stimulating factor in acute leukemia
    Y H Min
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Yonsei Med J 42:65-73. 2001
  5. ncbi request reprint AC133 antigen as a prognostic factor in acute leukemia
    S T Lee
    Department of Internal Medicine, Yonsei University College of Medicine, Seodaemun-ku Shinchon-dong 134, PO Box 8044, 120-752, Seoul, South Korea
    Leuk Res 25:757-67. 2001
  6. ncbi request reprint Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome
    S T Lee
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Am J Hematol 68:237-45. 2001
  7. doi request reprint Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation
    J Y Hong
    Division of Hematology Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    Transplant Proc 42:3723-8. 2010
  8. doi request reprint Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies
    I H Park
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Transfus Med 18:97-103. 2008
  9. ncbi request reprint Non-Hodgkin's lymphoma & primary biliary cirrhosis with Sjögren's syndrome
    J S Hahn
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Yonsei Med J 42:258-63. 2001
  10. ncbi request reprint The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery
    Y H Yun
    Cancer Research Institute, Seoul National University Hospital and College of Medicine, Seoul, Korea
    Ann Oncol 23:2731-7. 2012

Collaborators

  • S T Lee
  • J S Kim
  • Y W Kim
  • D H Lee
  • S J Kim
  • C Kim
  • Woo-Ick Yang
  • D H Kim
  • June Won Cheong
  • Jee Sook Hahn
  • Yun Woong Ko
  • Y H Yun
  • J Y Hong
  • Ju In Eom
  • Ho Young Maeng
  • S Park
  • I H Park
  • H W Moon
  • Hoyoung Maeng
  • D Y Noh
  • J S Hahn
  • S Y Jeong
  • I J Choi
  • D S Heo
  • S J Yoon
  • S J Park
  • Y J Won
  • C W Chung
  • M K Choi
  • W S Kim
  • K Kim
  • H O Kim
  • J H Jang
  • J W Song
  • J W Cheong
  • C J Park
  • S Shin
  • H C Kim
  • H Chun
  • H Y Kim
  • H I Cho
  • B K Kim
  • S S Yoon
  • Jae Hyun Lee
  • Hoi Kyung Jeung
  • So Young Chong
  • Gwi Eon Kim
  • Y Y Park
  • C O Suh
  • Y W Ko

Detail Information

Publications21

  1. ncbi request reprint Surface expression of HLA-DM on dendritic cells derived from CD34-positive bone marrow haematopoietic stem cells
    Y H Min
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Br J Haematol 110:385-93. 2000
    ..05). These results show that HLA-DM can be used as a useful DC lineage-specific marker, as well as a tool for the characterization of DCs and human immunotherapy...
  2. ncbi request reprint Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia
    Yoo Hong Min
    Department of Internal Medicine, Yonsei University College of Medicine, Seodaemun ku Shinchon dong 134, Seoul 120 752, Korea
    Cancer Res 64:5225-31. 2004
    ..These findings additionally extend our understanding of the role of p27Kip1 in AML, and buttress the case of p27Kip1 mislocalization as a prognostic indicator and Akt/PKB/p27Kip1 pathway as a ready target for antileukemia therapy...
  3. ncbi request reprint Long-term bone marrow culture-derived stromal fibroblasts as a potential target for gene therapy in acute myelogenous leukemia
    Yoo Hong Min
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
    Leuk Res 26:369-76. 2002
    ....
  4. ncbi request reprint Transplantation of peripheral blood stem cells mobilized by intensified consolidation and granulocyte colony-stimulating factor in acute leukemia
    Y H Min
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Yonsei Med J 42:65-73. 2001
    ..To further reduce the risk of leukemia relapse, much effort should be contributed to the field of ex vivo purging and post-transplant immunotherapy...
  5. ncbi request reprint AC133 antigen as a prognostic factor in acute leukemia
    S T Lee
    Department of Internal Medicine, Yonsei University College of Medicine, Seodaemun-ku Shinchon-dong 134, PO Box 8044, 120-752, Seoul, South Korea
    Leuk Res 25:757-67. 2001
    ..However, to verify the effect of AC133 expression on the therapeutic outcomes of adult acute leukemia, further study including more cases is needed...
  6. ncbi request reprint Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome
    S T Lee
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Am J Hematol 68:237-45. 2001
    ..We conclude that combination chemotherapy with intermediate dose cytarabine, idarubicin, and topotecan has significant antileukemic activity and acceptable toxicity in salvage AML and high-risk MDS...
  7. doi request reprint Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation
    J Y Hong
    Division of Hematology Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    Transplant Proc 42:3723-8. 2010
    ..7%. Allogeneic HSCT using RIC with fludarabine and melphalan appears to be feasible for a second HSCT in patients with relapsed hematologic malignancies after a failed autologous HSCT...
  8. doi request reprint Transfusion-associated iron overload as a predictive factor for poor stem cell mobilization in patients with haematological malignancies
    I H Park
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Transfus Med 18:97-103. 2008
    ..Iron chelation therapy prior to apheresis may be required to collect sufficient numbers of PBSCs in the iron overload patients...
  9. ncbi request reprint Non-Hodgkin's lymphoma & primary biliary cirrhosis with Sjögren's syndrome
    J S Hahn
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Yonsei Med J 42:258-63. 2001
    ..We documented a case of low-grade B-cell lymphoma of MALT in the right eyelid and primary biliary cirrhosis (PBC) of a patient with SS. To the best of our knowledge, this is the first case reported in Korea...
  10. ncbi request reprint The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery
    Y H Yun
    Cancer Research Institute, Seoul National University Hospital and College of Medicine, Seoul, Korea
    Ann Oncol 23:2731-7. 2012
    ..We conducted a population-based retrospective cohort study to investigate the influence of hospital volume, delay of surgery, and both together on the long-term survival of postoperative cancer patients...
  11. ncbi request reprint Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO+ acute myelogenous leukemia
    H W Moon
    Department of Laboratory Medicine, Ewha Womens University College of Medicine, Seoul, Korea
    Leukemia 20:1408-13. 2006
    ..We recommend that remission should be confirmed by FISH, because malignant clones can be differentiated and masked in morphological examination or chromosome test, especially for AML with AML1/ETO rearrangement...
  12. ncbi request reprint Constitutive phosphorylation of FKHR transcription factor as a prognostic variable in acute myeloid leukemia
    June Won Cheong
    Department of Internal Medicine, College of Medicine, Yonsei University, Seoul, South Korea
    Leuk Res 27:1159-62. 2003
    ..05). In conclusion, the constitutive phosphorylation of FKHR was observed in the majority of AML, and the detection of phospho-FKHR might provide a new tool for identifying AML patients with an unfavorable outcome...
  13. ncbi request reprint Therapeutic outcome of Epstein-Barr virus positive T/NK cell lymphoma in the upper aerodigestive tract
    Jee Sook Hahn
    Department of Internal Medicine, Yonsei University College of Medicine, C P O Box 8044, Seoul 120 752, Korea
    Yonsei Med J 43:175-82. 2002
    ....
  14. ncbi request reprint Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells
    June Won Cheong
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul 120 752, Korea
    Clin Cancer Res 9:5018-27. 2003
    ..The aim of this study was to examine the potential of apicidin to induce apoptosis in human Bcr-Abl-positive leukemia cells and to assess the mechanism of apicidin-induced apoptosis...
  15. ncbi request reprint Elevated S-phase kinase-associated protein 2 protein expression in acute myelogenous leukemia: its association with constitutive phosphorylation of phosphatase and tensin homologue protein and poor prognosis
    Yoo Hong Min
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Clin Cancer Res 10:5123-30. 2004
    ..However, the clinical significance of Skp2 in patients with acute myelogenous leukemia (AML) remains unknown...
  16. ncbi request reprint Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome
    June Won Cheong
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Br J Haematol 122:454-6. 2003
    ..05). Constitutive PTEN phosphorylation may add insight into the molecular pathogenesis of AML, and may be a new parameter for an unfavourable outcome...
  17. ncbi request reprint Chronic graft-versus-host disease of the liver presenting as an acute hepatitis following nonmyeloablative hematopoietic stem cell transplantation
    Hoyoung Maeng
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    Int J Hematol 79:501-4. 2004
    ..We conclude that a distinct syndrome of chronic hepatic GVHD presenting as an acute hepatitis should be considered as one possible explanation for hepatic dysfunction in patients who receive nonmyeloablative allogeneic HSCT...
  18. ncbi request reprint Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia
    Jin Seok Kim
    Department of Internal Medicine, Brain Korea 21 Research Team of Nanobiomaterials for the Cell Based Implants, Medical Research Center, Yonsei University College of Medicine, Seoul, Korea
    Clin Cancer Res 13:1019-28. 2007
    ..Protein kinase CK2 is implicated in cellular proliferation and transformation. However, the clinical and biological significances of CK2 have not been elucidated in acute myeloid leukemia (AML)...
  19. ncbi request reprint Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched hu
    Seung Tae Lee
    Department of Internal Medicine and BK21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
    Br J Haematol 118:1128-31. 2002
    ..We suggest that MSC can be used effectively for genetically haploidentical haematopoietic stem cell transplantation for acute leukaemia...
  20. ncbi request reprint Apicidin potentiates the imatinib-induced apoptosis of Bcr-Abl-positive human leukaemia cells by enhancing the activation of mitochondria-dependent caspase cascades
    Jin Seok Kim
    Department of Internal Medicine, National Health Insurance Corporation, Ilsan Hospital, Kyunggi Do, Korea
    Br J Haematol 124:166-78. 2004
    ..These findings generate a rationale for further investigation of apicidin and imatinib as a potential therapeutic strategy in Bcr-Abl-positive leukaemias...
  21. ncbi request reprint Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission
    Se Hoon Lee
    Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    Biol Blood Marrow Transplant 11:122-8. 2005
    ..We confirmed that high CD34(+) cell dose favorably affects the outcomes in allogeneic BMT for AML. The effort to attain a high CD34(+) cell dose should be pursued during bone marrow harvest in allogeneic BMT for AML in CR1...